Hemarina is a biotechnology company with a strong R&D activity. Our teams have a unique know-how, based on fifteen years of fundamental research. The results of our research are the subject of numerous scientific articles published in leading journals.
Beneficial effects of the novel marine oxygen carrier M101 during cold preservation of rat and human pancreas.
Journal of Cellular and Molecular Medicine. - 2019
Efficacy of the natural oxygen transporter HEMO2life® in cold preservation in a preclinical porcine model of donation after cardiac death.
Transplant International, official journal of the European Society for Organ Transplantation. - 2019
Preventing acute kidney injury during transplantation: the application of novel oxygen carriers.
Expert Opinion on Investigational Drugs, 28(7):643-657. - 2019
Individual and combined impact of oxygen and oxygen transporter supplementation during kidney machine preservation in a porcine preclinical kidney transplantation model.
International Journal of Molecular Sciences, 20(8). - 2019
Extracellular hemoglobin combined with an O2‐generating material overcomes O2 limitation in the bioartificial pancreas.
Biotechnology and Bioengineering, 116(5):1176-1189. - 2018
Prevention of ischemia-reperfusion lung injury during static cold preservation by supplementation of standard preservation solution with HEMO2life® in pig lung transplantation model.
Artificial Cells, Nanomedicine, and Biotechnology, 46(8):1773-1780. - 2018
Two-Day Lung Preservation Followed by Lung Transplantation in a Large Animal Model Using Novel Extracellular Oxygen Carrier.
The Journal of Heart and Lung Transplantation, - 2018